Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

sitafloxacin MeSH Supplementary Concept Data 2025


MeSH Supplementary
sitafloxacin
Unique ID
C076246
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C076246
Entry Term(s)
7-((7S)-amino-5-azaspiro(2,4)heptan-5-yl)-8-chloro-6-fluoro-1-((1R,2R)-cis-2-fluoro-1-cyclopropyl)-1,4-dihydro-4-oxoquinolone-3-carboxylic acid
7-(7-amino-5-azaspiro(2.4)heptan-5-yl)-8-chloro-6-fluoro-1-(2-fluorocyclopropyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid sesquihydrate
DU 6859
DU 6859A
DU-6859
DU-6859A
Pharm Action
Anti-Bacterial Agents
Topoisomerase II Inhibitors
Registry Numbers
9TD681796G
Related Numbers
127254-12-0
163253-35-8
CAS Type 1 Name
3-Quinolinecarboxylic acid, 7-(7-amino-5-azaspiro(2.4)hept-5-yl)-8-chloro-6-fluoro-1-(2-fluorocyclopropyl)-1,4-dihydro-4-oxo-, (1R-(1alpha(S*),2alpha))-
Heading Mapped to
*Fluoroquinolones
Frequency
188
Note
structure in first source
Source
Antimicrob Agents Chemother 1992 Jul;36(7):1491-8
Date of Entry
1992/09/21
Revision Date
2013/05/22
sitafloxacin Preferred
DU 6859A Narrower
DU-6859 Narrower
page delivered in 0.004s